For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

Scientists created mRNA inhaler that makes cells produce antiviral proteins. It protected cells from flu and Zika, and ...

In what sounds like the plot from a sci-fi movie, scientists have isolated an incredibly rare immune mutation to create a universal antiviral treatment. Only present in a few dozen people ...

A rare immune disorder has inspired a potential universal antiviral therapy. By mimicking the mutation s unique inflammation signature, researchers developed an mRNA-based treatment that stopped ...

There are a small group of people in the world who carry a unique feature in their DNA: a genetic mutation called ISG15 that ...

Despite current warning labels, oseltamivir is not linked to increased risk for neuropsychiatric events in pediatric patients ...

Health Canada has granted a medical device licence for Cepheid’s Xpert HCV VL Fingerstick, a test used to detect and quantify hepatitis C.

Scientists at Columbia University are developing a universal antiviral. This treatment aims to protect against many viruses, including influenza and COVID-19. The therapy is inspired by a rare genetic ...

There are two antiviral pills authorized by the U.S. Food and Drug Administration to treat COVID-19 at home: Pfizer's Paxlovid for people 12 and older, and Merck's molnupiravir for adults.

How Covid antiviral pills work and what that could mean for the pandemic Oral antivirals show huge promise for treating Covid-19. Here’s what they do in the body to fight the virus. Save ...

When given within five days of the onset of symptoms, the antiviral therapy, called Paxlovid, prevented almost 90% of deaths from COVID-19 compared with a placebo, a Pfizer study found.